These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8119916)

  • 21. Selective interactions of transforming and normal abl proteins with ATP, tyrosine-copolymer substrates, and tyrphostins.
    Anafi M; Gazit A; Gilon C; Ben-Neriah Y; Levitzki A
    J Biol Chem; 1992 Mar; 267(7):4518-23. PubMed ID: 1537837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tyrosine phosphorylation of P160 BCR by P210 BCR-ABL.
    Lu D; Liu J; Campbell M; Guo JQ; Heisterkamp N; Groffen J; Canaani E; Arlinghaus R
    Blood; 1993 Aug; 82(4):1257-63. PubMed ID: 8353288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of Src kinases p53/56lyn and p59hck by p210bcr/abl in myeloid cells.
    Danhauser-Riedl S; Warmuth M; Druker BJ; Emmerich B; Hallek M
    Cancer Res; 1996 Aug; 56(15):3589-96. PubMed ID: 8758931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the differentiation-associated p93 tyrosine protein kinase of HL-60 leukemia cells as the product of the human c-fes locus and its expression in myelomonocytic cells.
    Smithgall TE; Yu G; Glazer RI
    J Biol Chem; 1988 Oct; 263(29):15050-5. PubMed ID: 3170574
    [TBL] [Abstract][Full Text] [Related]  

  • 25. K562 leukemia cells transfected with the human c-fes gene acquire the ability to undergo myeloid differentiation.
    Yu G; Smithgall TE; Glazer RI
    J Biol Chem; 1989 Jun; 264(17):10276-81. PubMed ID: 2656706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tyrphostin AG957, a tyrosine kinase inhibitor with anti-BCR/ABL tyrosine kinase activity restores beta1 integrin-mediated adhesion and inhibitory signaling in chronic myelogenous leukemia hematopoietic progenitors.
    Bhatia R; Munthe HA; Verfaillie CM
    Leukemia; 1998 Nov; 12(11):1708-17. PubMed ID: 9823945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Establishment, characterization, and chromosomal analysis of new leukemic cell lines derived from MT/p210bcr/abl transgenic mice.
    Honda H; Ohno S; Takahashi T; Takatoku M; Yazaki Y; Hirai H
    Exp Hematol; 1998 Mar; 26(3):188-97. PubMed ID: 9502614
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p210BCR/ABL induces formation of complexes containing focal adhesion proteins and the protooncogene product p120c-Cbl.
    Salgia R; Sattler M; Pisick E; Li JL; Griffin JD
    Exp Hematol; 1996 Feb; 24(2):310-3. PubMed ID: 8641358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of STAT3 by the c-Fes protein-tyrosine kinase.
    Nelson KL; Rogers JA; Bowman TL; Jove R; Smithgall TE
    J Biol Chem; 1998 Mar; 273(12):7072-7. PubMed ID: 9507017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.
    Freed E; Hunter T
    Mol Cell Biol; 1992 Mar; 12(3):1312-23. PubMed ID: 1545812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL.
    Salgia R; Li JL; Lo SH; Brunkhorst B; Kansas GS; Sobhany ES; Sun Y; Pisick E; Hallek M; Ernst T
    J Biol Chem; 1995 Mar; 270(10):5039-47. PubMed ID: 7534286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. SH2-containing phosphotyrosine phosphatase Syp is a target of p210bcr-abl tyrosine kinase.
    Tauchi T; Feng GS; Shen R; Song HY; Donner D; Pawson T; Broxmeyer HE
    J Biol Chem; 1994 May; 269(21):15381-7. PubMed ID: 8195176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of p210bcr/abl by metallothionein promoter induced T-cell leukemia in transgenic mice.
    Honda H; Fujii T; Takatoku M; Mano H; Witte ON; Yazaki Y; Hirai H
    Blood; 1995 May; 85(10):2853-61. PubMed ID: 7537982
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells.
    Bhat A; Kolibaba K; Oda T; Ohno-Jones S; Heaney C; Druker BJ
    J Biol Chem; 1997 Jun; 272(26):16170-5. PubMed ID: 9195915
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BCR/ABL modulates the cytokine and retinoic acid response of c-Rel in human myeloid cells.
    Neumann M; Wilisch A; Ma BC; Druker BJ; Serfling E; Franza BR
    Anticancer Res; 1996; 16(3A):1075-83. PubMed ID: 8702216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tyrosine phosphorylated proteins in chronic myelogenous leukemia.
    Frackelton AR; Kumar PS; Kannan B; Clark JW
    Leuk Lymphoma; 1993; 11 Suppl 1():125-9. PubMed ID: 7504542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tyrphostin induced growth inhibition: correlation with effect on p210bcr-abl autokinase activity in K562 chronic myelogenous leukemia.
    Kaur G; Gazit A; Levitzki A; Stowe E; Cooney DA; Sausville EA
    Anticancer Drugs; 1994 Apr; 5(2):213-22. PubMed ID: 8049505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SH1 domain autophosphorylation of P210 BCR/ABL is required for transformation but not growth factor independence.
    Pendergast AM; Gishizky ML; Havlik MH; Witte ON
    Mol Cell Biol; 1993 Mar; 13(3):1728-36. PubMed ID: 8441409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of P210bcr-abl in mature granulocytes from Ph1-positive chronic myelogenous leukemia patients by an immunoblotting method.
    Kuwao F; Takahashi I
    Leukemia; 1993 Aug; 7(8):1168-73. PubMed ID: 8350617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.